Teva Pharmaceuticals- Norepinefrine Mexico's Unit Acquisition

Teva Pharmaceuticals- Norepinefrine Mexico raised a round of funding on March 20, 2017. Investors include OncBioMune Pharmaceuticals.

Teva Pharmaceutical Industries, headquartered in Israel, is a generic pharmaceutical company. Teva develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceut…

Articles about Teva Pharmaceuticals- Norepinefrine Mexico's Unit Acquisition: